AbCellera Biologics Inc - ABCL - stock price prediction, stock price target, analyst ratings from 9 analysts

AbCellera Biologics Inc has a share price target of US$ 17, revenue growth forecast of -66.4%, and profit growth estimate of -39.4% for FY26, based on top 9 analyst calls.